Molecule intelOpportunity: ModerateEssential

Potassium Iodide

39 brands · 24 companies · product forms

ATC: R05CA02, S01XA04, V03AB21 1 DRAP alert

Opportunity snapshot

Launch attractiveness
41
Market saturation
64
Price room
38
Regulatory risk
50
39
brands
24
companies
Rs 44.22
median price
34
price points
2.53x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 8%

Price room

Across observed sources and strengths
CheapestRs 30.5
MedianRs 44.22
Most expensiveRs 77.02
Spread2.53×
Sources: DRAP-official, DVAGO

max/min price ratio 2.53x across 34 trusted points (Rs 30.5-77.02). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Potassium Iodide — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2026-03-11
17. Volunatry Recall. Osilex-D (Glitz Pharma)

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(38) + 20% low-competition(36) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

24 canonical companies and 39 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 2.53x across 34 trusted points (Rs 30.5-77.02). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2026-03-11 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.